CVE-2024-44837
CVE-2024-44837 is a medium-severity vulnerability in Deathbreak Drug with a CVSS 3.x base score of 5.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.
Key facts
- Severity: Medium (CVSS 3.x base score 5.4)
- EPSS exploit prediction: 0% (21st percentile)
- Actively exploited: Not listed in CISA KEV
- EU (EUVD) id: EUVD-2024-41119
- Weakness: CWE-79
- Affected product: Deathbreak Drug
- Published:
- Last modified:
Description
A cross-site scripting (XSS) vulnerability in the component \bean\Manager.java of Drug v1.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the user parameter.
Frequently asked questions
- What is CVE-2024-44837?
- A cross-site scripting (XSS) vulnerability in the component \bean\Manager.java of Drug v1.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the user parameter.
- How severe is CVE-2024-44837?
- CVE-2024-44837 has a CVSS 3.x base score of 5.4, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
- Is CVE-2024-44837 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (21st percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2024-44837?
- CVE-2024-44837 affects Deathbreak Drug. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2024-44837?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- Does CVE-2024-44837 have an EU (EUVD) identifier?
- Yes. CVE-2024-44837 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-41119.
- When was CVE-2024-44837 published?
- CVE-2024-44837 was published on 2024-09-06 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:deathbreak:drug:1.0:*:*:*:*:*:*:*
Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities
- CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
- CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
- CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
- CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
- CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
- CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…
Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →